Skip to content
About Us
Vision & Mission
Founder/CEO Message
Leadership
Quality
CSR
Meaning of Sapala
Ownership
Services
By Area
Nucleic Acid Chemistry
Medicinal Chemistry
Carbohydrate Chemistry
Lipid and GalNAc Chemistry
Fluorescent Chemistry
By Engagement
CRO – FTE
CDMO – FFS
Analytical Services
Customized Model
By Industry
Academia
Start-ups (Biotech)
Oligo CDMOs
Therapeutic Companies
mRNA Vaccine Innovators
Sequencing Tech Makers
Products
Nucleoside and Phosphoramidites Derivatives
Linkers and Spacers
PEG Derivatives
Miscellaneous Products
Careers
Contact Us
Structure Search
Menu
About Us
Vision & Mission
Founder/CEO Message
Leadership
Quality
CSR
Meaning of Sapala
Ownership
Services
By Area
Nucleic Acid Chemistry
Medicinal Chemistry
Carbohydrate Chemistry
Lipid and GalNAc Chemistry
Fluorescent Chemistry
By Engagement
CRO – FTE
CDMO – FFS
Analytical Services
Customized Model
By Industry
Academia
Start-ups (Biotech)
Oligo CDMOs
Therapeutic Companies
mRNA Vaccine Innovators
Sequencing Tech Makers
Products
Nucleoside and Phosphoramidites Derivatives
Linkers and Spacers
PEG Derivatives
Miscellaneous Products
Careers
Contact Us
Structure Search
1-((2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
Category
Nucleoside and Phosphoramidites Derivatives
SNP-0037
6038-59-1
